HHS Expands COVID-19 Treatment Access Despite Coverage Shortfalls
September 27, 2022
Bloomberg Law (9/26, Subscription Publication) reports that HHS “will make commercially procured doses of the COVID-19 monoclonal antibody treatment bebtelovimab used on uninsured or underinsured patients replaceable by HHS for health care providers for f...